We are live on ! Find out more
ADMS

Adamas Pharmaceuticals
ADMS

Delisted

ADMS was delisted on the 23rd of November, 2021.

Back to rankings

89 hedge funds and large institutions have $268M invested in Adamas Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

520% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 5

113% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 15

77% more capital invested

Capital invested by funds: $151M → $268M (+$117M)

41% more funds holding

Funds holding: 63 → 89 (+26)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
89
Holders Change
+26
Holders Change %
+41.27%
% of All Funds
2.4%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
31
Increased
32
Reduced
15
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EAM
EverPoint Asset Management
Connecticut
+$7M
2
Renaissance Technologies
Renaissance Technologies
New York
+$3.81M
3
BFA
BlackRock Fund Advisors
California
+$3.6M
4
GPP
Great Point Partners
Connecticut
+$3.19M
5
BS
Bow Street
New York
+$2.47M

Top Sellers

Rank Fund Capital Flow
1
CPH
C Partners Holding
Switzerland
-$3.65M
2
OM
Opaleye Management
Massachusetts
-$2.04M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.2M
4
Marshall Wace
Marshall Wace
United Kingdom
-$1.04M
5
NI
Numeric Investors
Massachusetts
-$909K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$1.58M -$121K -6,211 -9%
SIM
27
Spark Investment Management
New York
$1.55M -$315K -16,200 -21%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$1.44M +$403K +20,716 +61%
Northern Trust
29
Northern Trust
Illinois
$1.36M +$260K +13,357 +35%
BA
30
BlackRock Advisors
Delaware
$1.3M +$45.4K +2,332 +5%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$1.29M +$132K +6,804 +16%
PAM
32
Private Asset Management
California
$1.25M – – –
EI
33
EAM Investors
California
$1.22M +$907K +46,655 New
Invesco
34
Invesco
Georgia
$1.08M +$801K +41,162 New
ZIM
35
Zacks Investment Management
Illinois
$1.05M +$778K +40,015 New
BIM
36
BlackRock Investment Management
Delaware
$1.03M +$595K +30,588 +357%
BOS
37
Bingham Osborn & Scarborough
California
$787K +$583K +30,000 New
Two Sigma Investments
38
Two Sigma Investments
New York
$781K +$580K +29,800 New
Wells Fargo
39
Wells Fargo
California
$758K +$507K +26,061 +926%
Bank of Montreal
40
Bank of Montreal
Ontario, Canada
$727K +$355K +18,266 +193%
BIM
41
Bogle Investment Management
Massachusetts
$712K +$528K +27,158 New
SO
42
STRS Ohio
Ohio
$710K -$169K -8,700 -24%
Point72 Asset Management
43
Point72 Asset Management
Connecticut
$708K +$525K +27,000 New
TAM
44
Tocqueville Asset Management
New York
$656K +$486K +25,000 New
UBS AM
45
UBS AM
Illinois
$587K +$435K +22,373 New
TCIM
46
TIAA CREF Investment Management
New York
$579K +$244K +12,569 +132%
DS
47
DRW Securities
Illinois
$572K +$424K +21,800 New
Asset Management One
48
Asset Management One
Japan
$499K – – –
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$498K +$265K +13,629 +255%
CS
50
Credit Suisse
Switzerland
$473K +$351K +18,053 New
1
2
3 4

ADMS Hedge Fund Activity: Q2 2015 in Review

89 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Adamas Pharmaceuticals (ADMS) for Q2 2015, worth a combined $268M — up 77% from $151M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new ADMS positions and 5 closed out — a net gain of 26 holders — while 32 added to existing stakes and 15 trimmed.

The largest buyer was EverPoint Asset Management, opening a new position worth an estimated $7M. The largest seller was C Partners Holding, cutting an estimated $3.65M.

  • 89 institutional investors held Adamas Pharmaceuticals (ADMS) as of Q2 2015, up from 63 in Q1 2015.
  • Funds reported $268M of Adamas Pharmaceuticals stock for Q2 2015, up 77% quarter-over-quarter.
  • 31 funds opened new Adamas Pharmaceuticals positions in Q2 2015 and 5 closed out, a net change of +26 holders.
  • The largest Adamas Pharmaceuticals buyer in Q2 2015 was EverPoint Asset Management, an estimated $7M added.
  • The largest Adamas Pharmaceuticals seller in Q2 2015 was C Partners Holding, an estimated $3.65M sold.

Based on aggregated 13F filings for Q2 2015.